For teams that want to explore oral delivery, BPC capsules receive similar treatment, with discussion of how to differentiate capsule-based protocols from injectable or in-vitro formats
This can degrade the compounds, reducing their potency and potentially rendering your research data invalid
Protocols place the injection within 12 cm of the target area where possible, since the peptide concentrates locally before distributing systemically
The FDAs own language makes it clear: Compounded drugs containing BPC-157 may pose risk for immunogenicity and may have complexities with regard to peptide-related impurities and API characterization. In plain terms, the FDA is worried about shady, unregulated research-use-only peptides sold online not about what happens when BPC-157 is responsibly compounded, tested for purity, and dispensed under medical supervision
As a result, they switch medications and resort to trial and error
Key Strengths: Curated peptide menu including BPC-157 and TB-500, compounded under strict USP 797 sterile protocols